Over-Expression of CHD4 Is an Independent Biomarker of Poor Prognosis in Patients with Rectal Cancers Receiving Concurrent Chemoradiotherapy

Neoadjuvant concurrent chemoradiotherapy (CCRT), followed by radical proctectomy, is the standard treatment for locally advanced rectal cancer. However, a poor response and therapeutic resistance continue to occur despite this treatment. In this study, we analyzed the microarray datasets (GSE68204)...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hui-Ching, Chou, Chia-Lin, Yang, Ching-Chieh, Huang, Wei-Lun, Hsu, Yin-Chou, Luo, Chi-Wen, Chen, Tzu-Ju, Li, Chien-Feng, Pan, Mei-Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747537/
https://www.ncbi.nlm.nih.gov/pubmed/31438571
http://dx.doi.org/10.3390/ijms20174087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747537/
https://www.ncbi.nlm.nih.gov/pubmed/31438571
http://dx.doi.org/10.3390/ijms20174087

Ejemplares similares